Non-invasive Healthcare Services / Digital Health / Wellness & Prevention
Strategic Profile
EUDA operates under a dual-segment model where property management services generate primary revenue while the non-invasive healthcare segment represents high-growth potential. The company positions itself as an innovator in Southeast Asian healthcare, leveraging proprietary technology to shift from reactive treatment to proactive, longevity-focused care and expanding into emerging immunotherapy applications.
Cyborg Score Rationale
EUDA demonstrates promising innovation in advanced healthcare therapies and regional market positioning, but faces significant challenges with minimal trailing revenue ($5.16M), a micro-cap market valuation ($42M), and a business model still dominated by property management. The healthcare segment shows strategic intent but lacks proven revenue traction to justify valuations relative to execution risk.
Top Insights
Dual-segment revenue model limits healthcare focus: property management services currently drive primary revenue, creating incentive misalignment with stated healthcare transformation mission
Strategic expansion into T-Cell immunotherapy indicates intent to diversify from stem cell and bioenergy offerings, but execution track record unproven at scale
Regional healthcare IT adoption accelerating (400% growth 2020) but EUDA's market penetration remains nascent with 117 employees serving multi-country operations
Named Competitors
Stem Cell Therapies — Direct competition in stem cell and regenerative medicine services
Digital Health Platforms — Competing for healthcare IT and digital connectivity solutions
Wellness & Prevention Services — Competing for preventative care and longevity-focused health solutions
Recent Developments
(Feb 2026) Stock trading at $1.11 with 37.8M shares outstanding; market cap $42M